CYIO Quote, Financials, Valuation and Earnings

Astrana Health, Inc. has a net margin of -- compared to CYIOS Corp.'s net margin of 0.69%. CYIOS Corp.'s return on equity of -- beat Astrana Health, Inc.'s return on equity of 4.49%.

CYIOS Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Astrana Health, Inc. has an analysts' consensus of $35.8889 which suggests that it could grow by 46.43%. Given that Astrana Health, Inc. has higher upside potential than CYIOS Corp., analysts believe Astrana Health, Inc. is more attractive than CYIOS Corp..

CYIOS Corp. has a beta of 0.318, which suggesting that the stock is 68.242% less volatile than S&P 500. In comparison Astrana Health, Inc. has a beta of 0.911, suggesting its less volatile than the S&P 500 by 8.944%.

CYIOS Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Astrana Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CYIOS Corp. pays -- of its earnings as a dividend. Astrana Health, Inc. pays out -- of its earnings as a dividend.

CYIOS Corp. quarterly revenues are --, which are smaller than Astrana Health, Inc. quarterly revenues of $950.5M. CYIOS Corp.'s net income of -- is lower than Astrana Health, Inc.'s net income of $6.6M. Notably, CYIOS Corp.'s price-to-earnings ratio is -- while Astrana Health, Inc.'s PE ratio is 73.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CYIOS Corp. is 0.03x versus 0.38x for Astrana Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Novo Integrated Sciences, Inc. has a net margin of -- compared to CYIOS Corp.'s net margin of -86.61%. CYIOS Corp.'s return on equity of -- beat Novo Integrated Sciences, Inc.'s return on equity of -49.15%.

CYIOS Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Novo Integrated Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that CYIOS Corp. has higher upside potential than Novo Integrated Sciences, Inc., analysts believe CYIOS Corp. is more attractive than Novo Integrated Sciences, Inc..

CYIOS Corp. has a beta of 0.318, which suggesting that the stock is 68.242% less volatile than S&P 500. In comparison Novo Integrated Sciences, Inc. has a beta of 0.631, suggesting its less volatile than the S&P 500 by 36.897%.

CYIOS Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Novo Integrated Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CYIOS Corp. pays -- of its earnings as a dividend. Novo Integrated Sciences, Inc. pays out -- of its earnings as a dividend.

CYIOS Corp. quarterly revenues are --, which are smaller than Novo Integrated Sciences, Inc. quarterly revenues of $3.2M. CYIOS Corp.'s net income of -- is lower than Novo Integrated Sciences, Inc.'s net income of -$2.7M. Notably, CYIOS Corp.'s price-to-earnings ratio is -- while Novo Integrated Sciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CYIOS Corp. is 0.03x versus 0.00x for Novo Integrated Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pacific Health Care Organization, Inc. has a net margin of -- compared to CYIOS Corp.'s net margin of 14.05%. CYIOS Corp.'s return on equity of -- beat Pacific Health Care Organization, Inc.'s return on equity of 11.97%.

CYIOS Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Health Care Organization, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that CYIOS Corp. has higher upside potential than Pacific Health Care Organization, Inc., analysts believe CYIOS Corp. is more attractive than Pacific Health Care Organization, Inc..

CYIOS Corp. has a beta of 0.318, which suggesting that the stock is 68.242% less volatile than S&P 500. In comparison Pacific Health Care Organization, Inc. has a beta of 0.097, suggesting its less volatile than the S&P 500 by 90.301%.

CYIOS Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pacific Health Care Organization, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.10 per share. CYIOS Corp. pays -- of its earnings as a dividend. Pacific Health Care Organization, Inc. pays out -- of its earnings as a dividend.

CYIOS Corp. quarterly revenues are --, which are smaller than Pacific Health Care Organization, Inc. quarterly revenues of $1.6M. CYIOS Corp.'s net income of -- is lower than Pacific Health Care Organization, Inc.'s net income of $223K. Notably, CYIOS Corp.'s price-to-earnings ratio is -- while Pacific Health Care Organization, Inc.'s PE ratio is 11.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CYIOS Corp. is 0.03x versus 2.40x for Pacific Health Care Organization, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

WW International has a net margin of -- compared to CYIOS Corp.'s net margin of -38.91%. CYIOS Corp.'s return on equity of -- beat WW International's return on equity of --.

CYIOS Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand WW International has an analysts' consensus of $1.10 which suggests that it could grow by 340.71%. Given that WW International has higher upside potential than CYIOS Corp., analysts believe WW International is more attractive than CYIOS Corp..

CYIOS Corp. has a beta of 0.318, which suggesting that the stock is 68.242% less volatile than S&P 500. In comparison WW International has a beta of 1.298, suggesting its more volatile than the S&P 500 by 29.755%.

CYIOS Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WW International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CYIOS Corp. pays -- of its earnings as a dividend. WW International pays out -- of its earnings as a dividend.

CYIOS Corp. quarterly revenues are --, which are smaller than WW International quarterly revenues of $186.6M. CYIOS Corp.'s net income of -- is lower than WW International's net income of -$72.6M. Notably, CYIOS Corp.'s price-to-earnings ratio is -- while WW International's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CYIOS Corp. is 0.03x versus 0.03x for WW International. Usually stocks with elevated PS ratios are considered overvalued.